PI3K Isoform Signalling in Platelets

Schrottmaier, Waltraud C.; Mußbacher, Marion; Salzmann, Manuel; Kral-Pointner, Julia B.; Assinger, Alice

doi:10.1007/978-3-031-06566-8_11

Cited by 1 publication

(1 citation statement)

References 115 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 36 Studies have confirmed that PI3K-dependent autophagy is necessary for maintaining essential platelet function. 7 , 37 Based on the above evidence, this study innovatively discovered that PDGFR was an upstream molecule of the platelet PI3K signaling pathway. H 2 S downregulated the activation of the PI3K/Akt/mTOR signaling pathway by inhibiting PDGFR phosphorylation, thereby promoting platelet autophagy.…”

Section: Discussionmentioning

confidence: 99%

Hydrogen Sulfide Promotes Platelet Autophagy via PDGFR-α/PI3K/Akt Signaling in Cirrhotic Thrombocytopenia

Yang,

Li,

et al. 2024

J Clin Transl Hepatol

View full text Add to dashboard Cite

Background and Aims The role of platelet autophagy in cirrhotic thrombocytopenia (CTP) remains unclear. This study aimed to investigate the impact of platelet autophagy in CTP and elucidate the regulatory mechanism of hydrogen sulfide (H 2 S) on platelet autophagy. Methods Platelets from 56 cirrhotic patients and 56 healthy individuals were isolated for in vitro analyses. Autophagy markers (ATG7, BECN1, LC3, and SQSTM1) were quantified using enzyme-linked immunosorbent assay, while autophagosomes were visualized through electron microscopy. Western blotting was used to assess the autophagy-related proteins and the PDGFR/PI3K/Akt/mTOR pathway following treatment with NaHS (an H 2 S donor), hydroxocobalamin (an H 2 S scavenger), or AG 1295 (a selective PDGFR-α inhibitor). A carbon tetrachloride-induced cirrhotic BALB/c mouse model was established. Cirrhotic mice with thrombocytopenia were randomly treated with normal saline, NaHS, or hydroxocobalamin for 15 days. Changes in platelet count and aggregation rate were observed every three days. Results Cirrhotic patients with thrombocytopenia exhibited significantly decreased platelet autophagy markers and endogenous H 2 S levels, alongside increased platelet aggregation, compared to healthy controls. In vitro, NaHS treatment of platelets from severe CTP patients elevated LC3-II levels, reduced SQSTM1 levels, and decreased platelet aggregation in a dose-dependent manner. H 2 S treatment inhibited PDGFR, PI3K, Akt, and mTOR phosphorylation. In vivo , NaHS significantly increased LC3-II and decreased SQSTM1 expressions in platelets of cirrhotic mice, reducing platelet aggregation without affecting the platelet count. Conclusions Diminished platelet autophagy potentially contributes to thrombocytopenia in cirrhotic patients. H 2 S modulates platelet autophagy and functions possibly via the PDGFR-α/PI3K/Akt/mTOR signaling pathway.

show abstract

Section: Discussionmentioning

confidence: 99%